The obesity market size is projected to witness growth from 2024 to 2034 due to the rising prevalence of obesity. This expansion is expected to be fu ...

Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate to severe UC patients.

The drugmaker Novo Nordisk can meet present and future demand in the U.S. for its drugs including Ozempic and Wegovy, the U.S ...

The big pharma sector is one that’s generally fallen out of favor for many investors over the past few decades, as large ...

Demand GLP-1 Medications as Prescription Drug Market GrowsSchaumburg, Illinois, Feb 21, 2025 - (ACN Newswire) - Giftify, Inc.

The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer in short supply. Elsewhere, Concentra made a ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Iterative Health, a healthcare technology and services company partnering with physicians to advance gastrointestinal care, ...

Juneteenth Foodways Festival is almost here, and The Benjamin Harrison Presidential Site is looking for Black-owned ...

Novo Nordisk A/S’s weight-loss and diabetes drugs are no longer in short supply, US regulators said, a decision that’s ...

Harvest Portfolios Group Inc. ("Harvest") announces the following distributions for Harvest High Income Shares ETFs for the month ending February 28, 2025. The distribution will be paid on or about ...